A trial looking at treatment for B cell non-Hodgkin lymphoma that has got worse (Glo-BNHL)

This trial is looking at different types of new medicines to treat B cell non-Hodgkin lymphoma that has come back after treatment or got worse during treatment.

The drugs currently being tested are odronextamab and loncastuximab tesirine with chemotherapy. Loncastuximab tesirine is also called lonca.

It is open to children and young adults up to and including the age of 25 with B cell non-Hodgkin lymphoma that has come back after treatment or got worse during treatment.

Cancer Research UK supports this trial.

You pronounce odronextamab as oh-dron-ex-ta-mab.

You pronounce loncastuximab tesirine as lon-cas-tuk-si-mab tes-i-reen.

Please note we use the term ‘you’ in this summary, but of course if you are a parent of a child with cancer, we are referring to your child.